XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Class A Common Stock
Common Stock
Class B Common Stock
Common Stock
Total Stockholders' Equity
Additional Paid-In Capital
Accumulated Deficit.
Noncontrolling Interests.
Total
Beginning balance at Dec. 31, 2020 $ 868 $ 162 $ 593,061 $ 909,278 $ (317,247) $ 112,821 $ 705,882
Beginning balance (in shares) at Dec. 31, 2020 86,812,647 16,221,101          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
ESPP shares issued     30 30   (1) 29
ESPP shares issued (in shares) 4,881            
Equity-based compensation     3,333 3,333   613 3,946
Issuance of restricted shares $ 19   1,900 1,881   (1,900)  
Issuance of restricted shares (in shares) 1,843,808            
Other     5 5     5
Other (in shares) 738            
Repurchase of common stock $ (2)   (1,225) (1,223)   19 (1,206)
Repurchase of common stock ( in shares) (199,976)            
Restricted shares forfeited $ (3)   (318) (315)   318  
Restricted shares forfeited (in shares) (301,395)            
Noncontrolling interest in subsidiary     (140) (140)   (934) (1,074)
NCI income tax adjustment     23 23   (23)  
Net income (loss)     (39,674)   (39,674) (7,362) (47,036)
Ending balance at Jun. 30, 2021 $ 882 $ 162 556,995 912,872 (356,921) 103,551 660,546
Ending balance (in shares) at Jun. 30, 2021 88,160,703 16,221,101          
Beginning balance at Mar. 31, 2021 $ 879 $ 162 571,375 910,688 (340,354) 106,574 677,949
Beginning balance (in shares) at Mar. 31, 2021 87,856,767 16,221,101          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
ESPP shares issued     16 16   (1) 15
ESPP shares issued (in shares) 2,736            
Equity-based compensation     2,131 2,131   393 2,524
Issuance of restricted shares $ 4   356 352   (356)  
Issuance of restricted shares (in shares) 356,360            
Other     5 5     5
Other (in shares) 738            
Repurchase of common stock $ (1)   (336) (335)   4 (332)
Repurchase of common stock ( in shares) (55,898)            
NCI income tax adjustment     15 15   (15)  
Net income (loss)     (16,567)   (16,567) (3,048) (19,615)
Ending balance at Jun. 30, 2021 $ 882 $ 162 556,995 912,872 (356,921) 103,551 660,546
Ending balance (in shares) at Jun. 30, 2021 88,160,703 16,221,101          
Beginning balance at Dec. 31, 2021 $ 942 $ 162 592,096 950,464 (359,472) 103,078 695,174
Beginning balance (in shares) at Dec. 31, 2021 94,172,920 16,221,101          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
ESPP shares issued     24 24   1 25
ESPP shares issued (in shares) 3,140            
Equity-based compensation     6,189 6,189   1,030 7,219
Issuance of shares for acquisitions $ 42   34,498 34,456   1,356 35,854
Issuance of shares for acquisition (in shares) 4,203,323            
Issuance of restricted shares $ 25   2,245 2,220   (2,245)  
Issuance of restricted shares (in shares) 2,529,231            
Stock options exercised $ 1   584 583   24 608
Stock options exercised (in shares) 70,000            
Repurchase of common stock $ (27)   (19,868) (19,841)   (436) (20,304)
Repurchase of common stock ( in shares) (2,754,923)            
Restricted shares forfeited $ (1)   (57) (56)   57  
Restricted shares forfeited (in shares) (63,118)            
NCI income tax adjustment     27 27   (24) 3
Net income (loss)     19,305   19,305 3,261 22,566
Ending balance at Jun. 30, 2022 $ 982 $ 162 635,043 974,066 (340,167) 106,102 741,145
Ending balance (in shares) at Jun. 30, 2022 98,160,573 16,221,101          
Beginning balance at Mar. 31, 2022 $ 981 $ 162 619,755 971,282 (352,670) 103,637 723,392
Beginning balance (in shares) at Mar. 31, 2022 98,111,119 16,221,101          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
ESPP shares issued     13 13     13
ESPP shares issued (in shares) 1,591            
Equity-based compensation     3,384 3,384   560 3,944
Issuance of restricted shares $ 2   173 171   (173)  
Issuance of restricted shares (in shares) 191,436            
Repurchase of common stock     (761) (761)   (27) (788)
Repurchase of common stock ( in shares) (94,595)            
Restricted shares forfeited $ (1)   (44) (43)   44  
Restricted shares forfeited (in shares) (48,978)            
NCI income tax adjustment     20 20   (17) 3
Net income (loss)     12,503   12,503 2,078 14,581
Ending balance at Jun. 30, 2022 $ 982 $ 162 $ 635,043 $ 974,066 $ (340,167) $ 106,102 $ 741,145
Ending balance (in shares) at Jun. 30, 2022 98,160,573 16,221,101